Bio-Gene Targets Flavocide Regulatory Filing As Japan Qcide Preparations Advance
BGT: $0.014 +7.69% · MC: $7M
Bio-Gene says it is targeting an initial Australian regulatory application for Flavocide in the second quarter of 2027, subject to completing studies and preparing the submission; draft reports for two key toxicity studies are under review. Work with Sumitomo and Nakashima on documentation and product development for Qcide supply to Japan continues, but timing for a first commercial order has not been agreed. The company also reported approximately $3 million in gross proceeds from its placement and share purchase plan, and received an R&D tax incentive of approximately $343,000 after quarter-end.

Comments